期刊文献+

临床分离细菌耐药性及药物应用分析 被引量:4

Separation of clinical drug resistance of bacteria and analysis of the drug application
在线阅读 下载PDF
导出
摘要 目的了解我院2011年临床分离菌的分布和耐药特征,指导临床合理使用抗菌药物。方法采用纸片扩散法进行抗菌药物敏感性试验,并对肠杆菌科细菌进行ESBLs检测,按CLSI 2009年标准判定药敏结果,用WHONET5.4软件进行数据分析。结果 2011年我院共分离细菌351株,其中革兰阴性杆菌268株,占76.4%,革兰阳性球菌83株,占23.6%。金黄色葡萄球菌和大肠埃希菌分别是革兰阳性球菌和革兰阴性杆菌的第一位。大肠埃希菌和肺炎克雷伯菌中ESBLs的检出率分别为58.5%和46.2%。葡萄球菌属中MRSA和MRCNS的检出率分别为76.5%和83.9%。结论从我院患者分离的细菌耐药性比较严重,应该加强监测,指导临床合理使用抗菌药物。 Objective To investigate the distribution and antibiotic resistance profile of common clinical isolates in Shenzhen Wujing Hospital during 2011. Methods Kirby-Bauer method was used to conduct susceptibility testing and ESBLs detection. The results were analyzed by WHONET 5.4 software according to CLSI 2009. Results Of the 351 clinical isolates, 76.4%(268/351) were gram-negative bacilli and 23.6% (83/351) were gram-positive cocci. S. aureus was the most common pathogen in gram-positive cocci. E. coli was the most frequently isolated pathogen in gram-nega- tive bacilli. ESBLs-producing strains were produced in 58.5% of E. coli and 46.2% of K. pneumoniae isolates respec- tively. Almost 76.5% of S. aureus isolates were MRSA, 83.9% of coagulase negative Staphylococcus isolates were me- thicillin-resistant. Conclusions Antimicrobial resistance in clinical bacterial isolates is a very serious problem in Wujing Hospital. Antimicrobial agents should be used rationally based on the results of susceptibility testing.
出处 《西部医学》 2013年第8期1254-1256,1259,共4页 Medical Journal of West China
关键词 抗菌药物 革兰阳性球菌 革兰阴性杆菌 细菌耐药性 Antimicrobial agent Gram positive coccus Gram negative bacillus Bacterial resistance
  • 相关文献

参考文献9

二级参考文献48

共引文献112

同被引文献52

  • 1产超广谱β-内酰胺酶细菌感染防治专家委员会.产超广谱β-内酰胺酶细菌感染防治专家共识[J].中华实验和I晦床感染病杂志,2010,4(2):51-54.
  • 2Song KH, Jeon JH, Park WB, et al. Clinical outcomes of spontane- ous bac-terial pentonitis due to extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella species : a retrospective matched case-control study[ J]. BMC Infect Dis,2009,9:41.
  • 3Dahmen S, Bettaieb D, Mansour W, et al. Characterization and mo- lecular epidemiology of extended-spectrum beta-lactamases in clini- cal isolates of Enterobacteriaceae in a Tunisian University Hospital J ]. Microbial drug resistance, 2010,16 ( 2 ) : 163 - 170.
  • 4Perez F, Endimiani A, Hujer KM, et al. The continuing challenge of ESBLs[ J]. Current opinion in pharmacology, 2007,7 ( 5 ) : 459 - 469.
  • 5Bradford PA. Extended-spectrum beta-lactamases in the 21 st centu-ry: characterization, epidemiology, and detection of this important resis-tance threat [ J ]. Clinical microbiology reviews, 2001,14 ( 4 ) : 933 - 951.
  • 6Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneu- moniae carbapenemase-producing bacteria [ J ]. The Lancet infec- tious diseases,2009,9 ( 4 ) : 228 - 236.
  • 7Lautenbach E, Weiner MG, Nachamkin I, et al. Imipenem resistance among pseudomonas aeruginosa isolates: risk fac'tors for infection and impact of resistance on clinical and economic outcomes[J]. Infect Control Hosp Epidemi- ol, 2006,27 (9) : 893-900.
  • 8Howden BP,Davies JK,Johnson PD, et al. Reduced van- comycin susceptibility in Staphylococcus aureus,including vancomycin-intermediate and heterogeneous vancomycin- intermediate strains: resistance mechanisms, laboratory detection, and clinical implications [J]. Clin Microbiol Rev,2010,23(1):99-139.
  • 9Sun WJ, Chen HB, Liu YD, et al. Prevalence and charac- terization of heterogeneous Vancomycin-Intermediate Staphylococcus aureus isolates from 14 cities in China[J]. Antimicrob Agents Chemother, 2009,53 ( 9 ) : 3642- 3649.
  • 10段宁,崔德健.氨基糖苷类抗生素进展与临床应用——抗感染合理用药专家圆桌会议纪要[J].中国医院用药评价与分析,2008,8(2):81-84. 被引量:16

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部